Novo Nordisk rebrands GLP-1s from medical treatment to lifestyle product
Novo Nordisk is shifting its marketing of GLP-1 drugs from medical necessity to lifestyle enhancement, using slogans like 'Live lighter' and referring to users as 'customers' rather than 'patients.' While these drugs offer significant weight loss and health benefits, experts warn that this consumer-focused approach ignores serious side effects, legal risks for prescribers, and the high costs that strain healthcare budgets.